nodes	percent_of_prediction	percent_of_DWPC	metapath
Nebivolol—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.00376	0.00376	CcSEcCtD
Nebivolol—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.00376	0.00376	CcSEcCtD
Nebivolol—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.00376	0.00376	CcSEcCtD
Nebivolol—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.00373	0.00373	CcSEcCtD
Nebivolol—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.00373	0.00373	CcSEcCtD
Nebivolol—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.00371	0.00371	CcSEcCtD
Nebivolol—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.00368	0.00368	CcSEcCtD
Nebivolol—Atrioventricular block—Epirubicin—peripheral nervous system neoplasm	0.00368	0.00368	CcSEcCtD
Nebivolol—Cardiac disorder—Vincristine—peripheral nervous system neoplasm	0.00367	0.00367	CcSEcCtD
Nebivolol—Mental disorder—Alitretinoin—peripheral nervous system neoplasm	0.00359	0.00359	CcSEcCtD
Nebivolol—Malnutrition—Alitretinoin—peripheral nervous system neoplasm	0.00357	0.00357	CcSEcCtD
Nebivolol—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.00356	0.00356	CcSEcCtD
Nebivolol—Acute coronary syndrome—Etoposide—peripheral nervous system neoplasm	0.00351	0.00351	CcSEcCtD
Nebivolol—Myocardial infarction—Etoposide—peripheral nervous system neoplasm	0.00349	0.00349	CcSEcCtD
Nebivolol—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.00348	0.00348	CcSEcCtD
Nebivolol—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.00348	0.00348	CcSEcCtD
Nebivolol—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.00348	0.00348	CcSEcCtD
Nebivolol—Mental disorder—Vincristine—peripheral nervous system neoplasm	0.00346	0.00346	CcSEcCtD
Nebivolol—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.00345	0.00345	CcSEcCtD
Nebivolol—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.00345	0.00345	CcSEcCtD
Nebivolol—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00345	0.00345	CcSEcCtD
Nebivolol—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00343	0.00343	CcSEcCtD
Nebivolol—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00343	0.00343	CcSEcCtD
Nebivolol—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00342	0.00342	CcSEcCtD
Nebivolol—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00342	0.00342	CcSEcCtD
Nebivolol—Atrioventricular block—Doxorubicin—peripheral nervous system neoplasm	0.00341	0.00341	CcSEcCtD
Nebivolol—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.00341	0.00341	CcSEcCtD
Nebivolol—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00338	0.00338	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00334	0.00334	CcSEcCtD
Nebivolol—Fatigue—Topotecan—peripheral nervous system neoplasm	0.00334	0.00334	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00332	0.00332	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00332	0.00332	CcSEcCtD
Nebivolol—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00331	0.00331	CcSEcCtD
Nebivolol—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00331	0.00331	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00327	0.00327	CcSEcCtD
Nebivolol—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00327	0.00327	CcSEcCtD
Nebivolol—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.00324	0.00324	CcSEcCtD
Nebivolol—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.0032	0.0032	CcSEcCtD
Nebivolol—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00317	0.00317	CcSEcCtD
Nebivolol—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00314	0.00314	CcSEcCtD
Nebivolol—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00314	0.00314	CcSEcCtD
Nebivolol—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.00314	0.00314	CcSEcCtD
Nebivolol—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00309	0.00309	CcSEcCtD
Nebivolol—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00308	0.00308	CcSEcCtD
Nebivolol—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00308	0.00308	CcSEcCtD
Nebivolol—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00306	0.00306	CcSEcCtD
Nebivolol—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00305	0.00305	CcSEcCtD
Nebivolol—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00305	0.00305	CcSEcCtD
Nebivolol—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.00304	0.00304	CcSEcCtD
Nebivolol—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.00304	0.00304	CcSEcCtD
Nebivolol—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00304	0.00304	CcSEcCtD
Nebivolol—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00304	0.00304	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.00302	0.00302	CcSEcCtD
Nebivolol—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00301	0.00301	CcSEcCtD
Nebivolol—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.00297	0.00297	CcSEcCtD
Nebivolol—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00287	0.00287	CcSEcCtD
Nebivolol—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00286	0.00286	CcSEcCtD
Nebivolol—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00285	0.00285	CcSEcCtD
Nebivolol—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00285	0.00285	CcSEcCtD
Nebivolol—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00283	0.00283	CcSEcCtD
Nebivolol—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00283	0.00283	CcSEcCtD
Nebivolol—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00283	0.00283	CcSEcCtD
Nebivolol—Renal failure acute—Epirubicin—peripheral nervous system neoplasm	0.00281	0.00281	CcSEcCtD
Nebivolol—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00279	0.00279	CcSEcCtD
Nebivolol—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00278	0.00278	CcSEcCtD
Nebivolol—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00276	0.00276	CcSEcCtD
Nebivolol—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00276	0.00276	CcSEcCtD
Nebivolol—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00275	0.00275	CcSEcCtD
Nebivolol—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00275	0.00275	CcSEcCtD
Nebivolol—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00274	0.00274	CcSEcCtD
Nebivolol—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00272	0.00272	CcSEcCtD
Nebivolol—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00272	0.00272	CcSEcCtD
Nebivolol—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00272	0.00272	CcSEcCtD
Nebivolol—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00271	0.00271	CcSEcCtD
Nebivolol—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00268	0.00268	CcSEcCtD
Nebivolol—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00265	0.00265	CcSEcCtD
Nebivolol—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00263	0.00263	CcSEcCtD
Nebivolol—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00263	0.00263	CcSEcCtD
Nebivolol—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00263	0.00263	CcSEcCtD
Nebivolol—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00261	0.00261	CcSEcCtD
Nebivolol—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.0026	0.0026	CcSEcCtD
Nebivolol—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.0026	0.0026	CcSEcCtD
Nebivolol—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.0026	0.0026	CcSEcCtD
Nebivolol—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00259	0.00259	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00257	0.00257	CcSEcCtD
Nebivolol—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00257	0.00257	CcSEcCtD
Nebivolol—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00256	0.00256	CcSEcCtD
Nebivolol—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00254	0.00254	CcSEcCtD
Nebivolol—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00254	0.00254	CcSEcCtD
Nebivolol—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00254	0.00254	CcSEcCtD
Nebivolol—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00252	0.00252	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00251	0.00251	CcSEcCtD
Nebivolol—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00251	0.00251	CcSEcCtD
Nebivolol—Vertigo—Etoposide—peripheral nervous system neoplasm	0.0025	0.0025	CcSEcCtD
Nebivolol—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00248	0.00248	CcSEcCtD
Nebivolol—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00246	0.00246	CcSEcCtD
Nebivolol—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00245	0.00245	CcSEcCtD
Nebivolol—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Nebivolol—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Nebivolol—Rash—Topotecan—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Nebivolol—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Nebivolol—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00243	0.00243	CcSEcCtD
Nebivolol—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00243	0.00243	CcSEcCtD
Nebivolol—Headache—Topotecan—peripheral nervous system neoplasm	0.00243	0.00243	CcSEcCtD
Nebivolol—Rash—Tretinoin—peripheral nervous system neoplasm	0.00242	0.00242	CcSEcCtD
Nebivolol—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00242	0.00242	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00242	0.00242	CcSEcCtD
Nebivolol—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00242	0.00242	CcSEcCtD
Nebivolol—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00242	0.00242	CcSEcCtD
Nebivolol—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00242	0.00242	CcSEcCtD
Nebivolol—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Nebivolol—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Nebivolol—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Nebivolol—Headache—Tretinoin—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Nebivolol—Rash—Melphalan—peripheral nervous system neoplasm	0.00239	0.00239	CcSEcCtD
Nebivolol—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00239	0.00239	CcSEcCtD
Nebivolol—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00238	0.00238	CcSEcCtD
Nebivolol—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00237	0.00237	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00235	0.00235	CcSEcCtD
Nebivolol—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Nebivolol—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Nebivolol—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Nebivolol—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.0023	0.0023	CcSEcCtD
Nebivolol—Nausea—Topotecan—peripheral nervous system neoplasm	0.0023	0.0023	CcSEcCtD
Nebivolol—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00229	0.00229	CcSEcCtD
Nebivolol—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00228	0.00228	CcSEcCtD
Nebivolol—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00228	0.00228	CcSEcCtD
Nebivolol—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00225	0.00225	CcSEcCtD
Nebivolol—Nausea—Melphalan—peripheral nervous system neoplasm	0.00225	0.00225	CcSEcCtD
Nebivolol—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Nebivolol—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Nebivolol—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00222	0.00222	CcSEcCtD
Nebivolol—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Nebivolol—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Nebivolol—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00216	0.00216	CcSEcCtD
Nebivolol—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Nebivolol—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00215	0.00215	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00214	0.00214	CcSEcCtD
Nebivolol—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00209	0.00209	CcSEcCtD
Nebivolol—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Nebivolol—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Nebivolol—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00204	0.00204	CcSEcCtD
Nebivolol—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00203	0.00203	CcSEcCtD
Nebivolol—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00202	0.00202	CcSEcCtD
Nebivolol—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00201	0.00201	CcSEcCtD
Nebivolol—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.002	0.002	CcSEcCtD
Nebivolol—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00199	0.00199	CcSEcCtD
Nebivolol—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00198	0.00198	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00196	0.00196	CcSEcCtD
Nebivolol—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00196	0.00196	CcSEcCtD
Nebivolol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00193	0.00193	CcSEcCtD
Nebivolol—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Nebivolol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00187	0.00187	CcSEcCtD
Nebivolol—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00186	0.00186	CcSEcCtD
Nebivolol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00186	0.00186	CcSEcCtD
Nebivolol—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Nebivolol—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00184	0.00184	CcSEcCtD
Nebivolol—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Nebivolol—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Nebivolol—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Nebivolol—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Nebivolol—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Nebivolol—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Nebivolol—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Nebivolol—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Nebivolol—Rash—Vincristine—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Nebivolol—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Nebivolol—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.00177	0.00177	CcSEcCtD
Nebivolol—Headache—Vincristine—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Nebivolol—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00173	0.00173	CcSEcCtD
Nebivolol—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.0017	0.0017	CcSEcCtD
Nebivolol—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Nebivolol—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00167	0.00167	CcSEcCtD
Nebivolol—Nausea—Vincristine—peripheral nervous system neoplasm	0.00167	0.00167	CcSEcCtD
Nebivolol—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.00166	0.00166	CcSEcCtD
Nebivolol—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.00163	0.00163	CcSEcCtD
Nebivolol—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00163	0.00163	CcSEcCtD
Nebivolol—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00161	0.00161	CcSEcCtD
Nebivolol—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00158	0.00158	CcSEcCtD
Nebivolol—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.00157	0.00157	CcSEcCtD
Nebivolol—Rash—Cisplatin—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Nebivolol—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Nebivolol—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Nebivolol—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00156	0.00156	CcSEcCtD
Nebivolol—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.00154	0.00154	CcSEcCtD
Nebivolol—Dizziness—Etoposide—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Nebivolol—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00147	0.00147	CcSEcCtD
Nebivolol—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Nebivolol—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Nebivolol—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.00144	0.00144	CcSEcCtD
Nebivolol—Rash—Etoposide—peripheral nervous system neoplasm	0.00143	0.00143	CcSEcCtD
Nebivolol—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00143	0.00143	CcSEcCtD
Nebivolol—Headache—Etoposide—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Nebivolol—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Nebivolol—Syncope—Epirubicin—peripheral nervous system neoplasm	0.0014	0.0014	CcSEcCtD
Nebivolol—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Nebivolol—Nausea—Etoposide—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Nebivolol—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Nebivolol—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Nebivolol—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.0013	0.0013	CcSEcCtD
Nebivolol—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Nebivolol—Shock—Epirubicin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Nebivolol—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Nebivolol—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Nebivolol—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.00124	0.00124	CcSEcCtD
Nebivolol—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.00123	0.00123	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Nebivolol—Shock—Doxorubicin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Nebivolol—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Nebivolol—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Nebivolol—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Nebivolol—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Nebivolol—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Nebivolol—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Nebivolol—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Nebivolol—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Nebivolol—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Nebivolol—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Nebivolol—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Nebivolol—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Nebivolol—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Nebivolol—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Nebivolol—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Nebivolol—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Nebivolol—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000964	0.000964	CcSEcCtD
Nebivolol—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000939	0.000939	CcSEcCtD
Nebivolol—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000937	0.000937	CcSEcCtD
Nebivolol—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000932	0.000932	CcSEcCtD
Nebivolol—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000914	0.000914	CcSEcCtD
Nebivolol—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000901	0.000901	CcSEcCtD
Nebivolol—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000872	0.000872	CcSEcCtD
Nebivolol—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000869	0.000869	CcSEcCtD
Nebivolol—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000846	0.000846	CcSEcCtD
Nebivolol—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000843	0.000843	CcSEcCtD
Nebivolol—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000834	0.000834	CcSEcCtD
Nebivolol—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00081	0.00081	CcSEcCtD
Nebivolol—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000807	0.000807	CcSEcCtD
Nebivolol—Rash—Epirubicin—peripheral nervous system neoplasm	0.000803	0.000803	CcSEcCtD
Nebivolol—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000803	0.000803	CcSEcCtD
Nebivolol—Headache—Epirubicin—peripheral nervous system neoplasm	0.000798	0.000798	CcSEcCtD
Nebivolol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00078	0.00078	CcSEcCtD
Nebivolol—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000757	0.000757	CcSEcCtD
Nebivolol—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00075	0.00075	CcSEcCtD
Nebivolol—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000743	0.000743	CcSEcCtD
Nebivolol—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000743	0.000743	CcSEcCtD
Nebivolol—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000739	0.000739	CcSEcCtD
Nebivolol—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.0007	0.0007	CcSEcCtD
